An Online Intervention to Reduce E-cigarette Use and Susceptibility to Smoking in Young Adults
Development of An Online, Theory-Based Intervention to Reduce E-cigarette Use and Susceptibility to Smoking in Young Adults: A Pilot Study
1 other identifier
interventional
100
1 country
1
Brief Summary
The goal of this intervention development and pilot clinical trial is to determine whether receiving the brief online intervention results in greater reductions in past 7-day e-cigarette use frequency and smoking susceptibility over an 8-week period compared to receiving the control condition in young adults who currently use e-cigarettes. Participants in the experimental condition will be asked to complete the 30-minute mobile-based program. Participants in the assessment-only control will be given the option to access the intervention after they complete their final survey at 8 weeks. All participants will complete our online surveys at baseline as well as 2-weeks, 4-weeks, and 8-weeks post-randomization. Researchers will compare outcomes among the intervention and control groups to determine the efficacy of the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2023
CompletedFirst Posted
Study publicly available on registry
November 13, 2023
CompletedStudy Start
First participant enrolled
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 23, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 23, 2026
CompletedJanuary 16, 2026
January 1, 2026
7 months
November 8, 2023
January 14, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
E-cigarette Use
Participants will report the number of (1) days they vaped, (2) times they picked up their device to vape per day, and (3) puffs they took before putting their vaping device away per day in the past 7 days and 30 days
8 weeks
Smoking Susceptibility
4-item Expanded Susceptibility to Smoking Index (ESSI)
8 weeks
Secondary Outcomes (6)
Perceived harms and benefits of vaping
8 weeks
Perceived harms and benefits of smoking
8 weeks
Motivation to vape
8 weeks
Motivation to smoke
8 weeks
Quitting vaping self-efficacy
8 weeks
- +1 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALParticipants will be asked to complete a 30-minute intervention that is accessible on a mobile device, delivered via a webpage, and personalized to their individual vaping behavior and beliefs (based on the baseline surveys). The intervention will contain personalized normative feedback (PNF), Motivational Enhancement (ME), and education. Participants will complete assessments at baseline as well as 2-weeks, 4-weeks, and 8-weeks post randomization.
Waitlist Control
NO INTERVENTIONParticipants will complete assessments at baseline as well as 2-weeks, 4-weeks, and 8-weeks post randomization. They will not receive the intervention during the active study phase, lasting 8 weeks. Participants will have the option to access the intervention once this active study phase is over.
Interventions
This is a 30-minute online educational program that focuses on providing information about e-cigarette and smoking social norms, harms of e-cigarettes and cigarettes, and ways to quit or reduce using e-cigarettes.
Eligibility Criteria
You may qualify if:
- be between the ages of 18 to 24
- be able to read English
- report vaping at least one day per week in the past month
- report no history of cigarette use at screening and baseline.
You may not qualify if:
- reporting severe mental health, illicit drug use, or alcohol use disorder
- currently receiving nicotine cessation services
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Southern California
Los Angeles, California, 90089, United States
Related Publications (1)
Tran DD, Davis JP, Buch K, Leventhal AM, Ewing SWF, Pedersen ER. A novel online vaping intervention and smoking prevention program for young adults who vape: protocol for a randomized controlled trial. Addict Sci Clin Pract. 2025 Apr 21;20(1):36. doi: 10.1186/s13722-025-00566-x.
PMID: 40259422DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Denise D Tran, PhD
University of Southern California
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 8, 2023
First Posted
November 13, 2023
Study Start
July 1, 2025
Primary Completion
January 23, 2026
Study Completion
January 23, 2026
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
No identifying participant information will be shared with other researchers. In the case where another researcher requests access to our data, we will de-identify our data set before sharing these data.